# Kv1.3 Therapeutics, Inc. — Form D

Kv1.3 Therapeutics, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-10. The offering totals $5.0M, of which $168K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-01-10
- Form: D
- Accession: 0001725094-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $168K
- Remaining: $4.8M
- Investors: 3
- Date of first sale: 2018-01-05
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-302850

## Issuer

- Name: Kv1.3 Therapeutics, Inc.
- CIK: 0001725094
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2017
- Address: 219 TERRY AVE. N., SEATTLE, WA, 98092
- Phone: 2063780400

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Lucien Fouke | Director | Seattle, WA |
| Robert Hedequist | Director | Seattle, WA |
| Shawn Iadonato | Director | Seattle, WA |
| Gavin Jancke | Director | SEATTLE, WA |
| Daniel Raymond | Director | Seattle, WA |
| Craig Philips | Executive Officer | Seattle, WA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2017-12-13](https://search.stillhousedata.com/formd/0001725094-17-000001) | D | $5.0M | $16K |

## More

- [CIK 1725094 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1725094&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001725094-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.